These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Maintenance of chronicity signatures in fibroblasts isolated from recessive dystrophic epidermolysis bullosa chronic wound dressings under culture conditions. De Gregorio C; Catalán E; Garrido G; Morandé P; Bennett JC; Muñoz C; Cofré G; Huang YL; Cuadra B; Murgas P; Calvo M; Altermatt F; Yubero MJ; Palisson F; South AP; Ezquer M; Fuentes I Biol Res; 2023 May; 56(1):23. PubMed ID: 37161592 [TBL] [Abstract][Full Text] [Related]
8. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development. Guerra L; Odorisio T; Zambruno G; Castiglia D Matrix Biol; 2017 Nov; 63():1-10. PubMed ID: 28126522 [TBL] [Abstract][Full Text] [Related]
9. Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa. Berthault C; Gaucher S; Gouin O; Schmitt A; Chen M; Woodley D; Titeux M; Hovnanian A; Izmiryan A J Invest Dermatol; 2024 Jun; 144(6):1322-1333.e13. PubMed ID: 38043638 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations. van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875 [TBL] [Abstract][Full Text] [Related]
11. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931 [TBL] [Abstract][Full Text] [Related]
12. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Tolar J; Ishida-Yamamoto A; Riddle M; McElmurry RT; Osborn M; Xia L; Lund T; Slattery C; Uitto J; Christiano AM; Wagner JE; Blazar BR Blood; 2009 Jan; 113(5):1167-74. PubMed ID: 18955559 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa. Cutlar L; Greiser U; Wang W Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073 [TBL] [Abstract][Full Text] [Related]
18. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector. Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967 [TBL] [Abstract][Full Text] [Related]
19. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Kim M; Murrell DF Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672 [TBL] [Abstract][Full Text] [Related]
20. A novel homozygous splice site mutation in COL7A1 in a Chinese patient with severe recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Huang L; Wong YP; Burd A Int J Dermatol; 2011 Jan; 50(1):52-6. PubMed ID: 21182502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]